|
HSP90AA1
|
Malignant neoplasm of breast
|
0.400 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
Neoplasm Metastasis
|
0.400 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
Breast Carcinoma
|
0.400 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
Mammary Neoplasms
|
0.350 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
Ki-1+ Anaplastic Large Cell Lymphoma
|
0.320 |
Biomarker |
CTD_human |
Our data demonstrate that targeting HSP90 function by 17-AAG may offer a novel therapeutic strategy for ALCL, either as single-agent activity or by combining 17-AAG with conventional or targeted therapeutic schemes.
|
17157164 |
2006 |
|
HSP90AA1
|
HIV Infections
|
0.310 |
Biomarker |
CTD_human |
Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment.
|
12878215 |
2003 |
|
HSP90AA1
|
Contact Dermatitis
|
0.300 |
Biomarker |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
HSP90AA1
|
Contact hypersensitivity
|
0.300 |
Biomarker |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
HSP90AA1
|
Cocaine withdrawal
|
0.300 |
Biomarker |
PSYGENET |
These results suggest a role for the posterior hippocampus in the neuroadaptations that occur during prolonged withdrawal, and point to a signaling partner of GR, HSP90AA1, as a novel dysregulated target during cocaine withdrawal.
|
22860061 |
2012 |
|
HSP90AA1
|
Unipolar Depression
|
0.300 |
Biomarker |
PSYGENET |
The Hsp90 cochaperone FK506 binding protein 5 (FKBP5) is an established regulator of the glucocorticoid receptor (GR), and numerous genetic studies have linked it to stress-related diseases such as major depression or posttraumatic stress disorder.
|
21907973 |
2011 |
|
HSP90AA1
|
Mood Disorders
|
0.300 |
Biomarker |
PSYGENET |
FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.
|
21907973 |
2011 |
|
HSP90AA1
|
Major Depressive Disorder
|
0.300 |
Biomarker |
PSYGENET |
The Hsp90 cochaperone FK506 binding protein 5 (FKBP5) is an established regulator of the glucocorticoid receptor (GR), and numerous genetic studies have linked it to stress-related diseases such as major depression or posttraumatic stress disorder.
|
21907973 |
2011 |
|
HSP90AA1
|
Mammary Neoplasms, Human
|
0.300 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
Mammary Carcinoma, Human
|
0.300 |
Biomarker |
CTD_human |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
20562527 |
2010 |
|
HSP90AA1
|
HIV Coinfection
|
0.300 |
Biomarker |
CTD_human |
Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment.
|
12878215 |
2003 |